1. Home
  2. PROF vs ICG Comparison

PROF vs ICG Comparison

Compare PROF & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • ICG
  • Stock Information
  • Founded
  • PROF N/A
  • ICG 2017
  • Country
  • PROF Canada
  • ICG China
  • Employees
  • PROF N/A
  • ICG N/A
  • Industry
  • PROF Medical/Dental Instruments
  • ICG Semiconductors
  • Sector
  • PROF Health Care
  • ICG Technology
  • Exchange
  • PROF Nasdaq
  • ICG Nasdaq
  • Market Cap
  • PROF 134.3M
  • ICG 112.7M
  • IPO Year
  • PROF N/A
  • ICG 2023
  • Fundamental
  • Price
  • PROF $4.09
  • ICG $1.85
  • Analyst Decision
  • PROF Strong Buy
  • ICG Strong Buy
  • Analyst Count
  • PROF 1
  • ICG 1
  • Target Price
  • PROF $11.00
  • ICG $7.50
  • AVG Volume (30 Days)
  • PROF 181.3K
  • ICG 198.4K
  • Earning Date
  • PROF 11-06-2025
  • ICG 08-14-2025
  • Dividend Yield
  • PROF N/A
  • ICG N/A
  • EPS Growth
  • PROF N/A
  • ICG N/A
  • EPS
  • PROF N/A
  • ICG 0.05
  • Revenue
  • PROF $11,840,000.00
  • ICG $43,282,895.00
  • Revenue This Year
  • PROF $60.07
  • ICG N/A
  • Revenue Next Year
  • PROF $121.80
  • ICG $69.92
  • P/E Ratio
  • PROF N/A
  • ICG $39.67
  • Revenue Growth
  • PROF 59.81
  • ICG 63.55
  • 52 Week Low
  • PROF $3.76
  • ICG $1.19
  • 52 Week High
  • PROF $9.17
  • ICG $12.04
  • Technical
  • Relative Strength Index (RSI)
  • PROF 35.14
  • ICG 42.08
  • Support Level
  • PROF $3.76
  • ICG $1.78
  • Resistance Level
  • PROF $4.69
  • ICG $2.16
  • Average True Range (ATR)
  • PROF 0.19
  • ICG 0.17
  • MACD
  • PROF -0.00
  • ICG 0.02
  • Stochastic Oscillator
  • PROF 33.67
  • ICG 27.91

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About ICG Intchains Group Limited

Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

Share on Social Networks: